Sirios Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-157,964
Closed -$5.79M 58
2023
Q2
$5.79M Sell
157,964
-9,748
-6% -$379K 1% 31
2023
Q1
$6.84M Sell
167,712
-6,025
-3% -$260K 1.21% 30
2022
Q4
$8.9M Buy
173,737
+4,596
+3% +$220K 1.64% 22
2022
Q3
$7.4M Sell
169,141
-14,778
-8% -$718K 1.37% 24
2022
Q2
$9.64M Sell
183,919
-163,619
-47% -$8.34M 1.74% 23
2022
Q1
$18M Sell
347,538
-116,609
-25% -$6.05M 2.39% 16
2021
Q4
$27.4M Sell
464,147
-128,290
-22% -$6.36M 3.14% 10
2021
Q3
$25.5M Buy
592,437
+17,929
+3% +$794K 2.67% 11
2021
Q2
$22.5M Sell
574,508
-182,489
-24% -$7.1M 1.96% 17
2021
Q1
$27.4M Sell
756,997
-654,513
-46% -$23.2M 2.31% 12
2020
Q4
$52M Buy
1,411,510
+155,420
+12% +$5.7M 4.04% 4
2020
Q3
$43.7M Sell
1,256,090
-100,918
-7% -$3.54M 3.57% 6
2020
Q2
$42.1M Sell
1,357,008
-344,655
-20% -$11.7M 3.43% 4
2020
Q1
$52.7M Buy
+1,701,663
New +$58M 4.66% 4

Other funds holding PFE

Sirios Capital Management's PFE Position: Q3 2023 in Review

Sirios Capital Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 157,964 shares — an estimated $5.79M sold.

Sirios Capital Management first reported a position in PFE in Q1 2020 and held it in 14 quarters. The position peaked at $52.7M in Q1 2020. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Sirios Capital Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Sirios Capital Management sold 157,964 Pfizer shares in Q3 2023, an estimated $5.79M.
  • Sirios Capital Management first reported a position in Pfizer in Q1 2020 and held it in 14 quarters.
  • Sirios Capital Management's Pfizer position peaked at $52.7M in Q1 2020.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Sirios Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.